Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus elagolix for endometriosis-associated pain
TCTR20250818011Phase 3Recruiting
- Sponsor
- Department of Obstetrics
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of letrozole and elagolix in endometriosis (2 arms), sponsored by Department of Obstetrics. Primary endpoint: Pain score reduction. Started Aug 2025; status: recruiting.
02
Drugs
letrozoleelagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on TCTR20250818011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250818011.